Skip to main content
Clinical Trials/ISRCTN13410498
ISRCTN13410498Completed未知

Effectiveness of a collaborative care intervention between pharmacies and primary care targeting hypertension and hyperlipidemia: a multi-centre quasi-experimental controlled trial (USFarmácia)

Associação Nacional das Farmácias0 sites688 target enrollmentStarted: December 12, 2018Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
688

Study Overview

Brief Summary

2022 Interim results article in https://pubmed.ncbi.nlm.nih.gov/36160402/ Cost-effectiveness and cost-utility (added 27/09/2022) 2023 Results article in https://doi.org/10.1371/journal.pone.0292308 (added 06/10/2023)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Patients of selected USF
  • 2. Age 18 years or older
  • 3. On medication for hypertension and/or hyperlipidemia
  • For technical reasons, intervention patients need to be holders of a NHS number, users of a mobile phone, registered in the NHS online portal Citizen Area, adherent to the National Association of Pharmacies (ANF) Pharmacy Loyalty Program Saúda®, with a Pharmacy Patient Medication Record.

Exclusion Criteria

  • Diabetic patients

Investigators

Sponsor
Associação Nacional das Farmácias

Similar Trials

Effectiveness of a collaborative care... | Clinical Trial